drugset / Trial / NCT05108025

DMT310-005 Topical in the Treatment of Acne Rosacea

NCT05108025

Phase 2 Unknown 180 enrolled Dermata Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne rosacea.

Timeline

Start
2021-11-15
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DMT310 Unknown Topical

Indications